R. R. Watkins and R. A. Bonomo, Overview: Global and Local Impact of Antibiotic Resistance, Infect Dis Clin North Am, vol.30, issue.2, p.27208761, 2016.

Z. Wang and G. Wang, APD: the Antimicrobial Peptide Database, Nucleic Acids Res, vol.32, p.14681488, 2004.

K. Splith and I. Neundorf, Antimicrobial peptides with cell-penetrating peptide properties and vice versa, Eur Biophys J, vol.40, issue.4, p.21336522, 2011.

S. Rotem and A. Mor, Antimicrobial peptide mimics for improved therapeutic properties, Biochim Biophys Acta, vol.1788, issue.8, p.19028449, 2009.

J. L. Fox, Antimicrobial peptides stage a comeback, Nat Biotechnol, vol.31, issue.5, p.23657384, 2013.

K. Midura-nowaczek and A. Markowska, Antimicrobial peptides and their analogs: searching for new potential therapeutics, Perspect Medicin Chem, vol.6, p.25374459, 2014.

Y. Y. Liu, Y. Wang, T. R. Walsh, L. X. Yi, R. Zhang et al., Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study, Lancet Infect Dis, vol.16, issue.2, p.26603172, 2016.

D. Vaudry, A. Falluel-morel, S. Bourgault, M. Basille, D. Burel et al., Pituitary adenylate cyclaseactivating polypeptide and its receptors: 20 years after the discovery, Pharmacol Rev, vol.61, issue.3, pp.283-357, 2009.
URL : https://hal.archives-ouvertes.fr/hal-02058111

S. Bourgault, D. Vaudry, A. Dejda, N. D. Doan, H. Vaudry et al., Pituitary adenylate cyclase-activating polypeptide: focus on structure-activity relationships of a neuroprotective Peptide, Curr Med Chem, vol.16, issue.33, p.19835562, 2009.

N. D. Doan, D. Chatenet, M. Letourneau, H. Vaudry, D. Vaudry et al., Receptor-independent cellular uptake of pituitary adenylate cyclase-activating polypeptide, Biochim Biophys Acta, vol.1823, issue.4, p.22343001, 2012.
URL : https://hal.archives-ouvertes.fr/pasteur-00819026

N. D. Doan, M. Letourneau, D. Vaudry, N. Doucet, B. Folch et al., Design and characterization of novel cell-penetrating peptides from pituitary adenylate cyclase-activating polypeptide, J Control Release, vol.163, issue.2, p.22922050, 2012.
URL : https://hal.archives-ouvertes.fr/pasteur-00818553

, Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 7th ed. CLSI document M7-A7, 2006.

J. W. Chung and D. P. Speert, Proteomic identification and characterization of bacterial factors associated with Burkholderia cenocepacia survival in a murine host, Microbiology, vol.153, p.17185549, 2007.

P. Gerhardt, Methods for general and molecular bacteriology, p.791, 1994.

M. Poujol-de-molliens, M. Letourneau, D. Devost, T. E. Hebert, A. Fournier et al., New insights about the peculiar role of the 28-38 C-terminal segment and some selected residues in PACAP for signaling and neuroprotection, Biochem Pharmacol, vol.154, p.29704474, 2018.
URL : https://hal.archives-ouvertes.fr/pasteur-01856091

B. Hess, C. Kutzner, D. Van-der-spoel, and L. E. Gromacs, Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation, J Chem Theory Comput, vol.4, issue.3, pp.435-482, 2008.
DOI : 10.1021/ct700301q

C. Oostenbrink, A. Villa, A. E. Mark, and W. F. Van-gunsteren, A biomolecular force field based on the free enthalpy of hydration and solvation: the GROMOS force-field parameter sets 53A5 and 53A6, J Comput Chem, vol.25, issue.13, p.15264259, 2004.

O. Berger, O. Edholm, and F. Jahnig, Molecular dynamics simulations of a fluid bilayer of dipalmitoylphosphatidylcholine at full hydration, constant pressure, and constant temperature, Biophys J, vol.72, issue.5, p.9129804, 1997.

B. Hess, H. Bekker, H. Berendsen, and J. Fraaije, LINCS: A linear constraint solver for molecular simulations, J Comp Chem, vol.18, pp.1463-72, 1997.

T. Darden, D. York, and L. Pedersen, Particle mesh Ewald: An N?log(N) method for Ewald sums in large systems, J Chem Phys, vol.98, pp.10089-92, 1993.

W. Kabsch and C. Sander, Dictionary of protein secondary structure: pattern recognition of hydrogenbonded and geometrical features, Biopolymers, vol.22, issue.12, p.6667333, 1983.

S. Bourgault, D. Vaudry, B. Botia, A. Couvineau, M. Laburthe et al., Novel stable PACAP analogs with potent activity towards the PAC1 receptor, Peptides, vol.29, issue.6, p.18353507, 2008.

S. Bourgault, D. Vaudry, I. Segalas-milazzo, L. Guilhaudis, A. Couvineau et al., Molecular and conformational determinants of pituitary adenylate cyclase-activating polypeptide (PACAP) for activation of the PAC1 receptor, J Med Chem, vol.52, issue.10, p.19413310, 2009.
URL : https://hal.archives-ouvertes.fr/pasteur-00819957

J. Gesell, M. Zasloff, and S. J. Opella, Two-dimensional 1H NMR experiments show that the 23-residue magainin antibiotic peptide is an alpha-helix in dodecylphosphocholine micelles, sodium dodecylsulfate micelles, and trifluoroethanol/water solution, J Biomol NMR, vol.9, issue.2, p.9090128, 1997.

A. S. Gislason, K. Turner, M. Domaratzki, and S. T. Cardona, Comparative analysis of the Burkholderia cenocepacia K56-2 essential genome reveals cell envelope functions that are uniquely required for survival in species of the genus, Burkholderia. Microb Genom, vol.3, issue.11, 2017.

S. Bourgault, D. Chatenet, O. Wurtz, N. D. Doan, J. Leprince et al., Strategies to convert PACAP from a hypophysiotropic neurohormone into a neuroprotective drug, Curr Pharm Des, vol.17, issue.10, p.21524253, 2011.
URL : https://hal.archives-ouvertes.fr/pasteur-00819519

N. D. Doan, S. Bourgault, A. Dejda, M. Letourneau, M. Detheux et al., Design and in vitro characterization of PAC1/VPAC1-selective agonists with potent neuroprotective effects, Biochem Pharmacol, vol.81, issue.4, p.21114961, 2011.
URL : https://hal.archives-ouvertes.fr/pasteur-00819506

P. Drevinek and E. Mahenthiralingam, Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence, Clin Microbiol Infect, vol.16, issue.7, p.20880411, 2010.

S. P. Conway, K. G. Brownlee, M. Denton, and D. G. Peckham, Antibiotic treatment of multidrug-resistant organisms in cystic fibrosis, Am J Respir Med, vol.2, issue.4, p.14719998, 2003.

L. A. Clifton, M. W. Skoda, E. L. Daulton, A. V. Hughes, L. Brun et al., Asymmetric phospholipid: lipopolysaccharide bilayers; a Gram-negative bacterial outer membrane mimic, J R Soc Interface, vol.10, issue.89, p.24132206, 2013.
DOI : 10.1098/rsif.2013.0810

URL : http://rsif.royalsocietypublishing.org/content/10/89/20130810.full.pdf

A. R. Brice and T. Lazaridis, Structure and dynamics of a fusion peptide helical hairpin on the membrane surface: comparison of molecular simulations and NMR, J Phys Chem B, vol.118, issue.17, p.24712538, 2014.

T. J. Silhavy, D. Kahne, and S. Walker, The bacterial cell envelope, Cold Spring Harb Perspect Biol, vol.2, issue.5, p.20452953, 2010.

A. Tchoumi-neree, P. T. Nguyen, D. Chatenet, A. Fournier, and S. Bourgault, Secondary conformational conversion is involved in glycosaminoglycans-mediated cellular uptake of the cationic cell-penetrating peptide PACAP, FEBS Lett, vol.588, issue.24, pp.4590-4596, 2014.